Susquehanna International Group’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.74M Buy
190,900
+58,200
+44% +$735K ﹤0.01% 6505
2025
Q4
$1.82M Sell
132,700
-55,700
-30% -$1.03M ﹤0.01% 5846
2025
Q3
$4.11M Buy
188,400
+127,600
+210% +$1.5M ﹤0.01% 4418
2025
Q2
$726K Sell
60,800
-108,300
-64% -$1.36M ﹤0.01% 8271
2025
Q1
$2.01M Sell
169,100
-144,400
-46% -$2.24M ﹤0.01% 5532
2024
Q4
$4.82M Buy
313,500
+282,400
+908% +$3.66M ﹤0.01% 3651
2024
Q3
$349K Buy
31,100
+16,800
+117% +$161K ﹤0.01% 9276
2024
Q2
$77.1K Sell
14,300
-46,300
-76% -$268K ﹤0.01% 11193
2024
Q1
$412K Buy
60,600
+21,000
+53% +$147K ﹤0.01% 8964
2023
Q4
$269K Sell
39,600
-200
-0.5% -$1.13K ﹤0.01% 10053
2023
Q3
$199K Buy
39,800
+24,100
+154% +$143K ﹤0.01% 10234
2023
Q2
$114K Sell
15,700
-700
-4% -$5.95K ﹤0.01% 10855
2023
Q1
$138K Buy
+16,400
New +$144K ﹤0.01% 10992
2022
Q4
Sell
-66,000
Closed -$684K 12534
2022
Q3
$684K Buy
66,000
+400
+0.6% +$5.27K ﹤0.01% 7626
2022
Q2
$856K Buy
+65,600
New +$670K ﹤0.01% 6908
2022
Q1
Sell
-27,900
Closed -$313K 13070
2021
Q4
$313K Sell
27,900
-33,800
-55% -$506K ﹤0.01% 10392
2021
Q3
$1.09M Buy
61,700
+24,500
+66% +$459K ﹤0.01% 7316
2021
Q2
$710K Buy
37,200
+19,300
+108% +$373K ﹤0.01% 8705
2021
Q1
$378K Buy
+17,900
New +$383K ﹤0.01% 10108

Other funds holding CLPT

Susquehanna International Group's CLPT Position: Q1 2026 in Review

Susquehanna International Group reduced its ClearPoint Neuro (CLPT) stake by 9.5% in Q1 2026, selling an estimated $180K and leaving 136,284 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #7336.

Susquehanna International Group first reported a position in CLPT in Q1 2021 and has held it in 18 quarters since. The position peaked at $7.83M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Susquehanna International Group held 136,284 shares of ClearPoint Neuro worth $1.24M as of Q1 2026.
  • Susquehanna International Group sold 14,272 ClearPoint Neuro shares in Q1 2026, an estimated $180K.
  • ClearPoint Neuro made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7336 holding.
  • Susquehanna International Group first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's ClearPoint Neuro position peaked at $7.83M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.